Your browser doesn't support javascript.
loading
41-Year-Old Male with Sub-Acute Encephalopathy, Seizures, and End Stage Renal Disease: A Unifying Diagnosis and Response to Therapy.
Wais, Tameena; Ibarra, Karen P; Sudarshana, Dattanand M; Eswarappa, Meghana; Park, Meyeon; Gallagher, Renata C; Tsui, Brian; Teixeira, Stephanie; Josephson, S Andrew; Richie, Megan.
Afiliación
  • Wais T; Department of Neurology, University of Arizona, Tucson, AZ, USA.
  • Ibarra KP; Department of Neurology and the Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Sudarshana DM; Department of Neurology and the Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Eswarappa M; Division of Nephrology, Department of Medicine, University of California, San Francisco, CA, USA.
  • Park M; Division of Nephrology, Department of Medicine, University of California, San Francisco, CA, USA.
  • Gallagher RC; Department of Pediatrics, University of California, San Francisco, CA, USA.
  • Tsui B; Department of Radiology, University of California, San Francisco, CA, USA.
  • Teixeira S; Department of Radiology, University of California, San Francisco, CA, USA.
  • Josephson SA; Department of Neurology and the Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Richie M; Department of Neurology and the Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
Neurohospitalist ; 14(1): 69-73, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38235033
ABSTRACT
We describe a case of a 41-year-old male with a history of end-stage renal disease, hypertension, epilepsy, ischemic stroke, and traumatic brain injury transferred to our tertiary care center for subacute, progressive cognitive impairment. He was found to have disproportionate brain atrophy, focal seizures, and refractory hypertension. Given suspicion for an underlying genetic etiology, a genetic panel for progressive renal disease was sent, revealing two known pathogenic variants in a gene for a cobalamin metabolism disorder, Cobalamin C deficiency. He was started on targeted metabolic supplementation with subsequent improvement in his cognition. Our case highlights the crucial need to expand diagnostic workup to include genetic and metabolic causes in patients with neurologic disease, atypical features, relevant family history and multi-organ dysfunction.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Neurohospitalist Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Neurohospitalist Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos